Determination of the Correlation between Her-2 Tumor Factor and Invasion of Breast Cancer to Axillary Lymph Nodes in Patients Undergoing Mastectomy in Cancer Institute (2001-2003)

Sirati, F; Yadegari, K

Volume 11, Issue 43 (12-2004) RJMS 2004, 11(43): 781-787 | Back to browse issues page

Mendeley

Zotero

RefWorks

Sirati F, Yadegari K. Determination of the Correlation between Her-2 Tumor Factor and Invasion of Breast Cancer to Axillary Lymph Nodes in Patients Undergoing Mastectomy in Cancer Institute (2001-2003). RJMS 2004; 11 (43) :781-787
URL: http://rjms.iums.ac.ir/article-1-74-en.html

Determination of the Correlation between Her-2 Tumor Factor and Invasion of Breast Cancer to Axillary Lymph Nodes in Patients Undergoing Mastectomy in Cancer Institute (2001-2003)

F Sirati

, K Yadegari

Abstract: (43376 Views)

Breast cancer is the most common site-specific cancer and is the second cause of mortality due to cancer in women. There are different prognostic factors including: axillary nodal status and tumor size(the most important factor), ER activity, PR, tumor grade and the type of histology. Other incompletely defined risk factors are: protease, catepstin, Her-2, etc. Her-2 is subtype 2 of EGF(Epidermal Growth Factor) receptor which may be presented in 10-34% of tumoral cells and is assumed to be a poor prognostic factor(probably because of high-power invasion of Her-2(+) tumors). The purpose of this study was to determine the correlation between Her-2 and invasion to axillary lymph nodes. For this purpose, all breast cancers operated betweed 2001-2003 in Imam Khomeini Cancer Institute were evaluated for size, age, menstural status, ER, PR, P53, Her-2 and axillary lymph node status. Of 134 patients, 50 cases(37.3%) were T1(Size<2cm), 62 cases(46.3%) T2(Size=2-5cm), 18 cases(13.4%) T3(Size>5cm) and 4 cases(3%) T4(any size with skin or chest wall involvement). All T3 and T4 cases had axillary lymph node involvement. Thus, there was no correlation between Her-2 and lymph node status. In T1, of 32 Her-2(+) patients, 21(67.7%) were LN+ (Lymph-node positive) and 11(32.3%) patients were LN-(Lymph-node negative) and of 18 Her-2(-) patients, 3(16.3%) were LN+ and 15(83.7%) were LN-. In T2, of 37 Her-2(+) patients, 29(78.3%) were LN+ and 8(21.7%) were LN- and of 25 Her-2(-) patients, 7(28%) were LN+ and 18(72%) were LN-. T1 and T2 tumors had direct correlation between Her-2 and lymph node involvement, (Pv<0.05), and this correlation was independent of age, ER, PR, P53, histology and menstrual status.

Keywords: Key Words: 1) Breast Cancer 2) Her-2 3) Tumor Marker

Full-Text [PDF 217 kb] (5876 Downloads)

Type of Study: Research | Subject: General Surgery